Wednesday, July 8, 2026

pharma · Acute Ischemic Stroke · Chronic Kidney Disease · DMAC

DiaMedica Therapeutics

News and analysis for DiaMedica Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

Minneapolis, USA HQ
45 Employees
Public company Type
DMAC · NYSE Ticker
Company details
Status
Public
HQ
Minneapolis, USA
Employees
45
Programs
8
Drugs
7
Patents
9
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning DiaMedica Therapeutics — regulatory, clinical, and market coverage.

News and analysis for DiaMedica Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning DiaMedica Therapeutics yet.

Back to company overview →